Hepatocyte growth factor promotes remodeling of murine liver fibrosis, accelerating recruitment of bone marrow-derived cells into the liver

Hepatology Research

Volumn 37, Issue 12, 2007, Pages 1080-1094

  Asano, Yasukane ^a   Iimuro, Yuji ^a   Son, Gakuhei ^a   Hirano, Tadamichi ^a   Fujimoto, Jiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Bone marrow cells; Gene transfer; Hepatocyte growth factor; Liver fibrosis; Stromal cell derived factor 1

Indexed keywords

ALPHA CHEMOKINE; BETA GALACTOSIDASE; CARBON TETRACHLORIDE; CHEMOKINE RECEPTOR CXCR4; GELATINASE; LIPOSOME; SCATTER FACTOR; SODIUM CHLORIDE; STROMAL CELL DERIVED FACTOR 1; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL COUNT; CELL TRANSPORT; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE TRANSFER; INHIBITION KINETICS; LIVER FIBROSIS; LIVER VEIN; MACROPHAGE; MITOGENESIS; MOUSE; NONHUMAN; PARAINFLUENZA VIRUS 1; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; SKELETAL MUSCLE; TISSUE REPAIR; TRANSGENIC MOUSE; TREATMENT DURATION; TREATMENT OUTCOME; UPREGULATION; VASCULAR ENDOTHELIUM; WHOLE BODY RADIATION;

EID: 35648931933     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00206.x     Document Type: Article

References (46)

1. Sobesky R, Mathurin P, Charlotte F et al. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view. The Multivirc Group. Gastroenterology 1999; 116: 378-86.
2. Hammel P, Couvelard A, O'Toole D et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 2001; 344: 418-23.
3. Ueki T, Kaneda Y, Tsutsui H et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999; 5: 226-30.
4. Petersen BE, Bowen WC, Patrene KD et al. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284: 1168-70.
5. Theise ND, Badve S, Saxena R et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 2000; 31: 235-40.
6. Lagasse E, Connors H, Al-Dhalimy M et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000; 6: 1229-34.
7. Theise ND, Nimmakayalu M, Gardner R et al. Liver from bone marrow in humans. Hepatology 2000; 32: 11-16.
8. Krause DS, Theise ND, Collector MI et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105: 369-77.
9. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-9.
10. Terada N, Hamazaki T, Oka M et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416: 542-5.
11. Schwartz RE, Reyes M, Koodie L et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002; 109: 1291-302.
12. Forbes SJ, Poulsom R, Wright NA. Hepatic and renal differentiation from blood-borne stem cells. Gene Ther 2002; 9: 625-30.
13. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003; 422: 901-4.
14. Wang X, Willenbring H, Akkari Y et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003; 422: 897-901.
15. Fujii H, Hirose T, Oe S et al. Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice. J Hepatol 2002; 36: 653-9.
16. Hatch HM, Zheng D, Jorgensen ML, Petersen BE. SDF-1alpha/CXCR4: A mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats. Cloning Stem Cells 2002; 4: 339-51.
17. Kollet O, Shivtiel S, Chen YQ et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003; 112: 160-9.
18. Boros P, Miller CM. Hepatocyte growth factor: A multifunctional cytokine. Lancet 1995; 345: 293-5.
19. Bussolino F, Di Renzo MF, Ziche M et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 119: 629-41.
20. Ding S, Merkulova-Rainon T, Han ZC, Tobelem G. HGF receptor upregulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. Blood 2003; 101: 4816-22.
21. Morishita R, Aoki M, Hashiya N et al. Therapeutic angiogenesis using hepatocyte growth factor (HGF). Curr Gene Ther 2004; 4: 199-206.
22. Morishita R, Aoki M, Hashiya N et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 2004; 44: 203-9.
23. Ishizawa K, Kubo H, Yamada M et al. Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochem Biophys Res Commun 2004; 324: 276-80.
24. Morishita R, Sugimoto T, Aoki M et al. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 1997; 3: 894-9.
25. Osamura RY, Komatsu N, Watanabe K, Nakai Y, Tanaka I, Imura H. Immunohistochemical and immunocytochemical localization of gamma-melanocyte stimulating hormone (gamma-MSH)-like immunoreactivity in human and rat hypothalamus. Peptides 1982; 3: 781-7.
26. Furukawa M, Magami Y, Azuma T et al. Proliferation and functional changes of pancreatic gastrin cells in neonatal rat. Pancreas 2001; 23: 421-6.
27. Sakaida I, Terai S, Yamamoto N et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 2004; 40: 1304-11.
28. Kuroiwa T, Kakishita E, Hamano T et al. Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function. J Clin Invest 2001; 107: 1365-73.
29. Paquet KJ, Kamphausen U. The carbon-tetrachloride-hepatotoxicity as a model of liver damage. First report: Long-time biochemical changes. Acta Hepatogastroenterol (Stuttg) 1975; 22: 84-8.
30. Sehested M, Hou-Jensen K. Factor VII related antigen as an endothelial cell marker in benign and malignant diseases. Virchows Arch A Pathol Anat Histol 1981; 391: 217-25.
31. Solovey AN, Gui L, Chang L, Enenstein J, Browne PV, Hebbel RP. Identification and functional assessment of endothelial P1H12. J Lab Clin Med 2001; 138: 322-31.
32. Terada R, Yamamoto K, Hakoda T et al. Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: Implications for inflammatory liver diseases. Lab Invest 2003; 83: 665-72.
33. Iredale JP, Benyon RC, Pickering J et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538-49.
34. Watanabe T, Niioka M, Hozawa S et al. Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride. J Hepatol 2000; 33: 224-35.
35. Iimuro Y, Nishio T, Morimoto T et al. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology 2003; 124: 445-58.
36. Issa R, Zhou X, Trim N et al. Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration. FASEB J 2003; 17: 47-9.
37. Higashiyama R, Inagaki Y, Hong YY et al. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology 2007; 45: 213-22.
38. Forbes SJ, Russo FP, Rey V et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004; 126: 955-63.
39. Kisseleva T, Uchinami H, Feirt N et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006; 45: 429-38.
40. Xin X, Yang S, Ingle G et al. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol 2001; 158: 1111-20.
41. Fujii K, Ishimaru F, Kozuka T et al. Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Br J Haematol 2004; 124: 190-4.
42. Miyazaki M, Akiyama I, Sakaguchi M et al. Improved conditions to induce hepatocytes from rat bone marrow cells in culture. Biochem Biophys Res Commun 2002; 298: 24-30.
43. De Meester I, Korom S, Van Damme J, Scharpe S. CD26, let it cut or cut it down. Immunol Today 1999; 20: 367-75.
44. Taniguchi E, Kin M, Torimura T et al. Endothelial progenitor cell transplantation improves the survival following liver injury in mice. Gastroenterology 2006; 130: 521-31.
45. Crosby HA, Kelly DA, Strain AJ. Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium. Gastroenterology 2001; 120: 534-44.
46. Xiao JC, Ruck P, Adam A, Wang TX, Kaiserling E. Small epithelial cells in human liver cirrhosis exhibit features of hepatic stem-like cells: immunohistochemical, electron microscopic and immunoelectron microscopic findings. Histopathology 2003; 42: 141-9.